Repositorio Digital

Initial Results and Long-Term Follow-up of Percutaneous Mitral Valvuloplasty in Patients with Pulmonary Hypertension

Mostrar el registro sencillo del ítem

dc.contributor.author Sarmiento, Ricardo
dc.contributor.author Blanco, Rodrigo
dc.contributor.author Gigena, Gerardo
dc.contributor.author Lax, Jorge
dc.contributor.author Escudero, Alejandro García
dc.contributor.author Blanco, Federico
dc.contributor.author Szarfer, Jorge
dc.contributor.author Solernó, Raúl
dc.contributor.author Tajer, Carlos
dc.contributor.author Gagliardi, Juan
dc.date.accessioned 2017-02-07T16:54:08Z
dc.date.available 2017-02-07T16:54:08Z
dc.date.issued 2017
dc.identifier.citation Initial Results and Long-Term Follow-up of Percutaneous Mitral Valvuloplasty in Patients with Pulmonary Hypertension Ricardo A. Sarmiento, Rodrigo Blanco, Gerardo Gigena, Jorge Lax, Alejandro Garcia Escudero, Federico Blanco, Jorge Szarfer, Raul Solerno, Carlos D. Tajer, Juan A. Gagliardi Heart, Lung and Circulation 2017 (26)1: p58–63. Available at: http://dx.doi.org/10.1016/j.hlc.2016.04.026 es_AR
dc.identifier.issn 1443-9506
dc.identifier.uri http://dx.doi.org/10.1016/j.hlc.2016.04.026
dc.identifier.uri http://repositorio.hospitalelcruce.org/xmlui/handle/123456789/467
dc.description Fil: Ricardo Sarmiento. Hospital de Alta Complejidad en Red El Cruce Dr. Néstor C. Kirchner. Servicio de Hemodinamia en Cardiopatías Congénitas. Florencio Varela, Argentina. es_AR
dc.description.abstract Background: Percutaneous balloon mitral valvuloplasty (PMV) is an attractive therapeutic approach in patients with mitral stenosis. The aim of this study was to assess the immediate and long-term clinical, echocardiographic and haemodynamic outcomes of PMV in patients with severe pulmonary hypertension (PAH). Methods: Percutaneous balloon mitral valvuloplasty was performed in 157 consecutive patients; 60 patients (38.2%) had significant PAH defined as baseline pulmonary artery mean pressure (PAMP) ≥ 30 mm Hg (Group 1) and 97 patients (61.8%) had PAMP ≤ 30 mmHg (Group 2). Pulmonary artery systolic pressure (PASP), mortality, need for mitral valve replacement or new PMV, and valve restenosis were evaluated during follow-up. Results: Mean age was 44.2 years and 88.5% (139 patients) were women. Primary success was achieved in 79.6% of the patients (125 patients) without differences between the groups. Mitral valve area increased from 0.90 cm2 to 1.76 cm2, PASP fell from 57 mmHg to 35 mmHg in Group 1 and from 38 mmHg to 30 mmHg in Group 2. Median PASP in Group 1 was 35, 32, 36, 38 and 34 mmHg at 12, 24, 36, 48 and 60 months. There were no significant differences in mitral valve area, PASP and clinical status between the groups. Conclusion: Percutaneous balloon mitral valvuloplasty is a safe and effective technique for the treatment of patients with mitral stenosis and PAH. A significant decrease in pulmonary pressure was observed after valvuloplasty. Although there was a gradual decrease of MVA at long-term follow-up, most patients remained asymptomatic and PASP was stable. es_AR
dc.language.iso en_US es_AR
dc.relation.ispartofseries Heart, Lung and Circulation;
dc.subject Valvuloplastia con Balón es_AR
dc.subject Estenosis de la Válvula Mitral es_AR
dc.subject Hemodinámica es_AR
dc.subject Hipertensión Pulmonar es_AR
dc.title Initial Results and Long-Term Follow-up of Percutaneous Mitral Valvuloplasty in Patients with Pulmonary Hypertension es_AR
dc.type Article es_AR


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem